As of 2025-11-04, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,637.68 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 11.9x | 11.2x |
| Forward P/E multiples | 9.8x - 11.7x | 10.4x |
| Fair Price | (30.92) - (32.67) | (30.55) |
| Upside | -123.9% - -125.2% | -123.6% |
| Date | EV/EBITDA |